Risk Assessment

Bioactivation of procarcinogens: positive and negative regulation

E Bresnick

Familial predisposition and genetic susceptibility

JE Garber, Assist Prof Medicine

Cofactorial oncogene functions

Eric J. Stanbridge, PhD

Mutagen sensitivity as a marker of cancer susceptibility

MR Spitz

DNA and protein adducts for identification of exposure to carcinogens and genetic biomarkers as intermediate endpoints

Gerald N. Wogan

New approaches to in situ hybridization

HJ Wolfe